Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 576

  • Unknown field was ignored: [Corporate%25252520Author].
1.

α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.

van Steenoven I, Majbour NK, Vaikath NN, Berendse HW, van der Flier WM, van de Berg WDJ, Teunissen CE, Lemstra AW, El-Agnaf OMA.

Mov Disord. 2018 Nov 15. doi: 10.1002/mds.111. [Epub ahead of print]

PMID:
30440090
2.

Spontaneous oscillatory markers of cognitive status in two forms of dementia.

Shah-Basak PP, Kielar A, Deschamps T, Verhoeff NP, Jokel R, Meltzer J.

Hum Brain Mapp. 2018 Nov 12. doi: 10.1002/hbm.24470. [Epub ahead of print]

PMID:
30421472
3.

Military-related risk factors for dementia.

Snyder HM, Carare RO, DeKosky ST, de Leon MJ, Dykxhoorn D, Gan L, Gardner R, Hinds SR 2nd, Jaffee M, Lamb BT, Landau S, Manley G, McKee A, Perl D, Schneider JA, Weiner M, Wellington C, Yaffe K, Bain L, Pacifico AM, Carrillo MC.

Alzheimers Dement. 2018 Nov 1. pii: S1552-5260(18)33520-9. doi: 10.1016/j.jalz.2018.08.011. [Epub ahead of print] Review.

4.

Mild cognitive impairment in long-term brain tumor survivors following brain irradiation.

Cramer CK, McKee N, Case LD, Chan MD, Cummings TL, Lesser GJ, Shaw EG, Rapp SR.

J Neurooncol. 2018 Nov 7. doi: 10.1007/s11060-018-03032-8. [Epub ahead of print]

PMID:
30406339
5.

TLR4 inhibitor TAK-242 attenuates the adverse neural effects of diet-induced obesity.

Moser VA, Uchoa MF, Pike CJ.

J Neuroinflammation. 2018 Nov 5;15(1):306. doi: 10.1186/s12974-018-1340-0.

6.

Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients.

Perry W, Lacritz L, Roebuck-Spencer T, Silver C, Denney RL, Meyers J, McConnel CE, Pliskin N, Adler D, Alban C, Bondi M, Braun M, Cagigas X, Daven M, Drozdick L, Foster NL, Hwang U, Ivey L, Iverson G, Kramer J, Lantz M, Latts L, Maria Lopez A, Malone M, Martin-Plank L, Maslow K, Melady D, Messer M, Most R, Norris MP, Shafer D, Thomas CM, Thornhill L, Tsai J, Vakharia N, Waters M, Golden T.

Clin Neuropsychol. 2018 Aug - Oct;32(7):1193-1225. doi: 10.1080/13854046.2018.1517503.

PMID:
30396329
7.

Variation in TMEM106B in chronic traumatic encephalopathy.

Cherry JD, Mez J, Crary JF, Tripodis Y, Alvarez VE, Mahar I, Huber BR, Alosco ML, Nicks R, Abdolmohammadi B, Kiernan PT, Evers L, Svirsky S, Babcock K, Gardner HM, Meng G, Nowinski CJ, Martin BM, Dwyer B, Kowall NW, Cantu RC, Goldstein LE, Katz DI, Stern RA, Farrer LA, McKee AC, Stein TD.

Acta Neuropathol Commun. 2018 Nov 4;6(1):115. doi: 10.1186/s40478-018-0619-9.

8.

Associations of Lifestyle Behaviour and Healthy Ageing in Five Latin American and the Caribbean Countries-A 10/66 Population-Based Cohort Study.

Daskalopoulou C, Koukounari A, Ayuso-Mateos JL, Prince M, Prina AM.

Nutrients. 2018 Oct 30;10(11). pii: E1593. doi: 10.3390/nu10111593.

9.

Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [18F]Flortaucipir PET.

Risacher SL, Farlow MR, Bateman DR, Epperson F, Tallman EF, Richardson R, Murrell JR, Unverzagt FW, Apostolova LG, Bonnin JM, Ghetti B, Saykin AJ.

Acta Neuropathol Commun. 2018 Oct 29;6(1):114. doi: 10.1186/s40478-018-0608-z.

10.

Weight-Loss Outcomes from a Pilot Study of African Dance in Older African Americans.

Stillman CM, Donahue PT, Williams MF, Callas M, Lwanga C, Brown C, Wollam ME, Jedrziewski MK, Kang C, Erickson KI.

Obesity (Silver Spring). 2018 Oct 25. doi: 10.1002/oby.22331. [Epub ahead of print]

PMID:
30358132
11.

Mediterranean Lifestyle in Relation to Cognitive Health: Results from the HELIAD Study.

Anastasiou CA, Yannakoulia M, Kontogianni MD, Kosmidis MH, Mamalaki E, Dardiotis E, Hadjigeorgiou G, Sakka P, Tsapanou A, Lykou A, Scarmeas N.

Nutrients. 2018 Oct 20;10(10). pii: E1557. doi: 10.3390/nu10101557.

12.

Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients.

Perry W, Lacritz L, Roebuck-Spencer T, Silver C, Denney RL, Meyers J, McConnel CE, Pliskin N, Adler D, Alban C, Bondi M, Braun M, Cagigas X, Daven M, Drozdick L, Foster NL, Hwang U, Ivey L, Iverson G, Kramer J, Lantz M, Latts L, Ling SM, Lopez AM, Malone M, Martin-Plank L, Maslow K, Melady D, Messer M, Most R, Norris MP, Shafer D, Silverberg N, Thomas CM, Thornhill L, Tsai J, Vakharia N, Waters M, Golden T.

Arch Clin Neuropsychol. 2018 Sep 1;33(6):655-675. doi: 10.1093/arclin/acy052. No abstract available.

13.

When is Alzheimer's not dementia-Cochrane commentary on The National Institute on Ageing and Alzheimer's Association Research Framework for Alzheimer's Disease.

McCleery J, Flicker L, Richard E, Quinn TJ.

Age Ageing. 2018 Oct 17. doi: 10.1093/ageing/afy167. [Epub ahead of print]

PMID:
30329009
14.

Elderly Latino community members make an educational video: an academic-community collaboration to promote memory evaluations.

Neugroschl J, Sewell MC, Umpierre M, Rodriguez R, Meyers L, Kranes S, Aldrete C, Collazo A, Valois L, Sano M.

Int Psychogeriatr. 2018 Oct 15:1-7. doi: 10.1017/S1041610218001448. [Epub ahead of print]

PMID:
30318026
15.

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.

Shaw LM, Arias J, Blennow K, Galasko D, Molinuevo JL, Salloway S, Schindler S, Carrillo MC, Hendrix JA, Ross A, Illes J, Ramus C, Fifer S.

Alzheimers Dement. 2018 Nov;14(11):1505-1521. doi: 10.1016/j.jalz.2018.07.220. Epub 2018 Oct 10. Review.

PMID:
30316776
16.

Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology.

Sierksma A, Lu A, Salta E, Vanden Eynden E, Callaerts-Vegh Z, D'Hooge R, Blum D, Buée L, Fiers M, De Strooper B.

Mol Neurodegener. 2018 Oct 12;13(1):54. doi: 10.1186/s13024-018-0285-1.

17.

Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease.

Maraki MI, Yannakoulia M, Stamelou M, Stefanis L, Xiromerisiou G, Kosmidis MH, Dardiotis E, Hadjigeorgiou GM, Sakka P, Anastasiou CA, Simopoulou E, Scarmeas N.

Mov Disord. 2018 Oct 10. doi: 10.1002/mds.27489. [Epub ahead of print]

PMID:
30306634
18.

Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease.

Johnson ECB, Dammer EB, Duong DM, Yin L, Thambisetty M, Troncoso JC, Lah JJ, Levey AI, Seyfried NT.

Mol Neurodegener. 2018 Oct 4;13(1):52. doi: 10.1186/s13024-018-0282-4.

19.

Adolescent exposure to Δ9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons.

Miller ML, Chadwick B, Dickstein DL, Purushothaman I, Egervari G, Rahman T, Tessereau C, Hof PR, Roussos P, Shen L, Baxter MG, Hurd YL.

Mol Psychiatry. 2018 Oct 3. doi: 10.1038/s41380-018-0243-x. [Epub ahead of print]

PMID:
30283037
20.

Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.

Lim SL, Tran DN, Zumkehr J, Chen C, Ghiaar S, Kieu Z, Villanueva E, Gallup V, Rodriguez-Ortiz CJ, Kitazawa M.

Glia. 2018 Sep 12. doi: 10.1002/glia.23522. [Epub ahead of print]

PMID:
30277607

Supplemental Content

Loading ...
Support Center